Search

Your search keyword '"Corpechot, Christophe"' showing total 596 results

Search Constraints

Start Over You searched for: Author "Corpechot, Christophe" Remove constraint Author: "Corpechot, Christophe"
596 results on '"Corpechot, Christophe"'

Search Results

2. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.

3. Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis

4. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis

5. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation

6. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study

7. The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial

9. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

10. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

15. Non-invasive diagnosis and follow-up in liver transplantation

18. THU-107 Short- and medium-term effects of hypnosis and psychoeducational interventions on fatigue associated with primary biliary cholangitis: a randomized controlled trial

19. LBP-040 Long-term efficacy and safety of open-label seladelpar treatment in patients with primary biliary cholangitis (PBC): interimresults for 2 years from the ASSURE study

20. LBP-027 Combined effect of obeticholic acid and bezafibrate in patients with primary biliary cholangitis and inadequate response or intolerance to ursodeoxycholic acid: 6-month results from a phase 2 trial

21. THU-125 Key questions that patients with primary biliary cholangitis should ask their physician -Delphi method-

22. THU-102-YI Specific glycomic profiles can identify patients at risk of poor transplant-free survival in primary biliary cholangitis

23. GS-007 Prospective validation of the prognostic value of liver stiffness assessed by Fibroscan in primary sclerosing cholangitis: final results of the FICUS study

24. THU-111 Second-line treatment in recurrent primary biliary cholangitis after liver transplantation: an international multicentre study

25. LBP-006 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial

26. THU-098 Appraising gain of an extended 2-year placebo-controlled trial in primary biliary cholangitis: challenges for evaluating clinical outcomes

27. THU-136 The epidemiological and prognostic burden of autoimmune liver disease: results of a nationwide population-based study over the past decade

28. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with Primary Biliary Cholangitis- an ELTR study

32. Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe

33. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

35. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study

36. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

41. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis

42. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

43. Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

44. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival

45. Autoimmune hepatitis recurrence after liver transplantation: “Les jeux sont faits”.

46. Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool

49. Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Catalog

Books, media, physical & digital resources